Jeff Bailey

Jeff Bailey is a seasoned executive with extensive experience in the life sciences and pharmaceutical sectors. Currently serving as a Board Member for Aurinia Pharmaceuticals Inc. and as a Board of Trustees member at Aberdeen Funds following the acquisition of Tekla Capital Healthcare Management. Jeff was previously Chairman of the Board of Trustees at Tekla Capital Management and Chairman of the Board of Directors at Aileron Therapeutics, where a significant merger was completed. Additional leadership roles include CEO positions at BioDelivery Sciences International and IlluminOss Medical Inc., both of which were successfully acquired. Jeff has also contributed to various boards, including ImaginAb and LANDAUER, while overseeing significant acquisitions in the industry. Education was obtained at Rutgers University.